Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
2.
Neuro Oncol ; 19(5): 678-688, 2017 05 01.
Article in English | MEDLINE | ID: mdl-28453747

ABSTRACT

Background: Anaplastic gangliogliomas (GGGs) are rare tumors whose natural history is poorly documented. We aimed to define their clinical and imaging features and to identify prognostic factors. Methods: Consecutive cases of anaplastic GGGs in adults prospectively entered into the French Brain Tumor Database between March 2004 and April 2014 were screened. After diagnosis was confirmed by pathological review, clinical, imaging, therapeutic, and outcome data were collected retrospectively. Results: Forty-three patients with anaplastic GGG (median age, 49.4 y) from 18 centers were included. Presenting symptoms were neurological deficit (37.2%), epileptic seizure (37.2%), or increased intracranial pressure (25.6%). Typical imaging findings were unifocal location (94.7%), contrast enhancement (88.1%), central necrosis (43.2%), and mass effect (47.6%). Therapeutic strategy included surgical resection (95.3%), adjuvant radiochemotherapy (48.8%), or radiotherapy alone (27.9%). Median progression-free survival (PFS) and overall survival (OS) were 8.0 and 24.7 months, respectively. Three- and 5-year tumor recurrence rates were 69% and 100%, respectively. The 5-year survival rate was 24.9%. Considering unadjusted significant prognostic factors, tumor midline crossing and frontal location were associated with shorter OS. Temporal and parietal locations were associated with longer and shorter PFS, respectively. None of these factors remained statistically significant in multivariate analysis. Conclusions: We report a large series providing clinical, imaging, therapeutic, and prognostic features of adult patients treated for an intracerebral anaplastic GGG. Our results show that pathological diagnosis is difficult, that survivals are only slightly better than for glioblastomas, and that complete surgical resection followed with adjuvant chemoradiotherapy offers longer survival.


Subject(s)
Brain Neoplasms/pathology , Combined Modality Therapy/mortality , Ganglioglioma/pathology , Adolescent , Adult , Aged , Brain Neoplasms/therapy , Databases, Factual , Disease Progression , Female , Follow-Up Studies , Ganglioglioma/therapy , Humans , Male , Middle Aged , Prognosis , Retrospective Studies , Survival Rate , Young Adult
3.
Am J Surg Pathol ; 39(7): 948-56, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25786084

ABSTRACT

Chordoid glioma of the third ventricle (CG3V) is a rare tumor developing in a stereotyped localization. It has been related to the circumventricular organ of the lamina terminalis, in the anterior part of the third ventricle, but its oncogenesis is poorly understood. TTF-1 transcription factor is involved in the development and adult physiology of the ventral forebrain. We studied the histopathologic and immunohistochemical features of a multicentric series of 17 cases of CG3V. We described additional histologic patterns (solid, fibrosing, and fusiform) to the typical chordoid pattern. TTF-1 was constantly expressed in CG3V, as in developing and adult lamina terminalis. The anti-TTF-1 SPT24 clone was more sensitive than the 8G7G3/1 clone. No mutation of IDH1 R132, IDH2 R172, or BRAF V600 codons was found. We showed TTF-1 as a useful marker for the diagnosis of CG3V and the understanding of its oncogenesis.


Subject(s)
Cerebral Ventricle Neoplasms/metabolism , Cerebral Ventricle Neoplasms/pathology , Glioma/metabolism , Glioma/pathology , Nuclear Proteins/biosynthesis , Organum Vasculosum/metabolism , Third Ventricle/metabolism , Transcription Factors/biosynthesis , Adult , Aged , Female , Humans , Male , Middle Aged , Retrospective Studies , Thyroid Nuclear Factor 1
4.
Am J Surg Pathol ; 36(6): 916-28, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22588068

ABSTRACT

Neuroepithelial papillary tumor of the pineal region (PTPR) has been defined as a distinct entity that is increasingly being recognized, with 96 cases now reported. This tumor shares morphologic features with both ependymomas and choroid plexus tumors. PTPR is characterized by an epithelial-like growth pattern in which the vessels are covered by layers of tumor cells forming perivascular pseudorosettes. These tumors exhibit various combinations of papillary and solid architecture, making the differential diagnosis of PTPR difficult to establish. We report the detailed description of the histopathologic features of a large series of PTPRs from 20 different centers and distinguish 2 subgroups of tumors with either a striking papillary growth pattern or a papillary and solid growth pattern. We highlight the findings that PTPRs have unusual vessels with multiple lumina and frequently show detachment of the border of the tumoral cells from the vascular wall. The 2 PTPR subgroups present similar clinical characteristics and immunophenotypes. We confirmed and extended the results of previous ultrastructural studies on the presence of intercellular junctions at the apical part of tumoral cells. The expression of the tight junction proteins claudin-1, claudin-2, and claudin-3 was investigated by immunohistochemistry. Claudin-1 and claudin-3, but not claudin-2, were expressed in PTPRs and in the fetal subcommissural organ, potentially the origin of this tumor. In contrast, all 3 claudins were expressed in choroid plexus papillomas. Claudin expression may help in the diagnosis of PTPRs and can be used in combination with other markers, such as CK18, NCAM, E-cadherin, MAP-2, and Kir 7.1.


Subject(s)
Carcinoma, Papillary/pathology , Claudins/metabolism , Pinealoma/pathology , Tight Junctions/metabolism , Adolescent , Adult , Aged , Biomarkers, Tumor/metabolism , Carcinoma, Papillary/diagnostic imaging , Carcinoma, Papillary/metabolism , Child , Child, Preschool , Female , Humans , Male , Middle Aged , Pinealoma/metabolism , Pinealoma/surgery , Tight Junctions/ultrastructure , Ultrasonography , Young Adult
5.
J Inherit Metab Dis ; 34(2): 515-22, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21161685

ABSTRACT

Danon disease is an X-linked lysosomal disorder, characterized by hypertrophic cardiomyopathy, skeletal myopathy and mental retardation. We report a family with a novel mutation, in which the mother and her three sons were affected with various clinical presentations. A massive hypertrophy of the left ventricle was the predominant feature in the three male patients, with different degrees of severity of cardiac symptoms, from isolated palpitations to cardiac failure and sudden death. Muscle pain and weakness were also variable, but constantly associated with increased plasma CK levels. Finally, the male patients had variable degree of a mental retardation. The mother had an attenuated phenotype, limited to a mild hypertrophic cardiomyopathy with premature ventricular contractions diagnosed during her 40's. Microscopy examination of skeletal muscle biopsy, performed in the youngest patient, demonstrated atrophic myofibers with intracytoplasmic vacuoles suggesting lysosomal glycogen storage disease. Immunohistochemistry analyses in muscle specimen showed no detectable Lysosomal-Associated Membrane Protein-2 (LAMP-2), in keeping with the diagnosis of Danon disease. However, a very low expression of a shortened LAMP-2 protein could be evidenced by Western-blot in the patient's fibroblasts. Molecular investigations identified a novel splicing mutation (IVS6 + 1delG) in the LAMP-2 gene. This case report highlights the intrafamilial variability of Danon disease phenotype. In this case, morphological examination of muscle biopsy, showing lysosomal storage myopathy, and immunohistochemistry analyses can provide key elements for orienting etiologic investigations.


Subject(s)
Glycogen Storage Disease Type IIb/diagnosis , Glycogen Storage Disease Type IIb/genetics , Lysosomal Membrane Proteins/genetics , Mutation , Adolescent , Adult , Biopsy , Child , Female , Genetic Variation , Humans , Immunohistochemistry/methods , Intellectual Disability/genetics , Lysosomal-Associated Membrane Protein 2 , Lysosomes/pathology , Male , Muscle, Skeletal/metabolism , Phenotype
6.
Acta Neurochir (Wien) ; 152(10): 1755-60, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20628888

ABSTRACT

We present three cases of meningiomas developing at the site of an old head trauma. We then review the literature regarding the controversies on the development of post-traumatic brain tumors and, finally, we emphasize the medico-legal characteristics of post-traumatic meningiomas, particularly with respect to their cell type which is frequently atypical or anaplastic and which have a poor outcome.


Subject(s)
Craniocerebral Trauma/pathology , Meningeal Neoplasms/pathology , Meningioma/pathology , Skull Fractures/pathology , Adult , Aged , Arachnoid/diagnostic imaging , Arachnoid/injuries , Arachnoid/pathology , Craniocerebral Trauma/diagnostic imaging , Craniocerebral Trauma/etiology , Dura Mater/diagnostic imaging , Dura Mater/injuries , Dura Mater/pathology , Humans , Male , Meningeal Neoplasms/diagnostic imaging , Meningeal Neoplasms/etiology , Meningioma/diagnostic imaging , Meningioma/etiology , Radiography , Skull Fractures/diagnostic imaging , Skull Fractures/etiology
9.
J Biomed Mater Res A ; 84(1): 92-8, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17600319

ABSTRACT

We aimed to study the influence of hydroxyapatite (HA) coating and polymethylmethacrylate (PMMA) cement on the risk of development of stainless steel implant-site infection with Staphylococcus epidermidis in a sheep model. Uncoated, HA-coated, and PMMA-cemented stainless steel implants were inserted in the left femur of 30 sheep. For each type of implant, sheep were inoculated with S. epidermidis in the intramedullary canal and one non-inoculated group was used as control. After 6 weeks, infection was evaluated using clinical, radiological, bacteriological, and histological criteria. Radiological and clinical results were normal. Cultures were negative in the control sheep. In the inoculated sheep, interposition tissue and bone cultures were positive in 2 of 6 uncoated, 6 of 6 HA, and 6 of 6 PMMA implants with a mean bacteria count of 5.2 +/- 1.17, 3.5 +/- 0.7, and 3.9 +/- 0.9 log10 cfu/g, respectively (NS), for interposition tissue, and 4 +/- 0.01, 2.9 +/- 0.6, and 2.5 +/- 1.3 log10 cfu/g, respectively (NS) for bone. The polymorphonuclear leukocyte (PMN) score (mean number of PMN per 10 different microscopic high-power fields >or=5) in interposition tissue was >or=3 in 6 of 6 HA, significantly different from uncoated (3 of 6) and PMMA (2 of 6) groups (p = 0.04). The HA and PMMA inoculated groups had a higher infection rate than the uncoated inoculated group (p = 0.06). In this experimental sheep model of S. epidermidis infection at the bone-biomaterial interface, HA seems to be at higher risk of infection compared with uncoated or PMMA-cemented stainless steel, when inoculation is intramedullary and contemporary with implantation.


Subject(s)
Durapatite/chemistry , Polymethyl Methacrylate/chemistry , Prostheses and Implants/adverse effects , Stainless Steel/chemistry , Staphylococcal Infections/pathology , Staphylococcus epidermidis/physiology , Animals , Bone and Bones/microbiology , Disease Models, Animal , Sheep , Synovial Membrane/microbiology
10.
J Neurooncol ; 77(2): 153-9, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16292482

ABSTRACT

Gangliogliomas are unusual central nervous system (CNS) neoplasms occurring mainly in children and young adults and inducing chronic pharmacoresistant epilepsy. These are usually well differentiated neuroepithelial tumors composed of neurons in association with neoplastic glial cells. Gangliogliomas present with favorable outcome. However, some may recur and/or progress to anaplasia and be associated with a dismal prognosis. Since histopathological features do not consistently correlate with clinical outcome, reliable prognostic factors have yet to be defined in gangliogliomas. Survivin is an anti-apoptotic protein whose expression has been found to be of prognostic significance in many human cancers, including gliomas. The objective of this study was to assess survivin expression using immunohistochemistry in 15 gangliogliomas. Ten lesions were low-grade neoplasms whereas 5 were high-grade tumors. Survivin expression appeared restricted to the neoplastic glial component and was detected in 6/15 gangliogliomas. Two additional tumors expressed survivin upon relapse. Half survivin expressing lesions displayed less than 1% immunoreactive cells. Survivin expression in more than 5% neoplastic glial cells was detected only in malignant and/or recurrent gangliogliomas. Extended lifespan in survivin expressing cells might enhance aggressive behavior in these tumors through accumulation of mutations, thereby allowing progression to malignant phenotypes. Survivin expression may carry a negative prognostic value in gangliogliomas.


Subject(s)
Biomarkers, Tumor/analysis , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Ganglioglioma/metabolism , Ganglioglioma/pathology , Microtubule-Associated Proteins/biosynthesis , Neoplasm Proteins/biosynthesis , Adolescent , Adult , Aged , Brain Neoplasms/mortality , Child , Female , Ganglioglioma/mortality , Humans , Immunohistochemistry , Infant , Inhibitor of Apoptosis Proteins , Magnetic Resonance Imaging , Male , Middle Aged , Prognosis , Survivin
SELECTION OF CITATIONS
SEARCH DETAIL
...